Tables S1-S8 and Figure Legends from Novel Gene and Network Associations Found for Acute Lymphoblastic Leukemia Using Case–Control and Family-Based Studies in Multiethnic Populations

Priyanka Nakka,Natalie P. Archer,Heng Xu,Philip J. Lupo,Benjamin J. Raphael,Jun J. Yang,Sohini Ramachandran

DOI: https://doi.org/10.1158/1055-9965.22437879

2023-01-01

Abstract:Supplementary Tables S1-S8 and Supplementary Figure Legends.

What problem does this paper attempt to address?

Supplementary Tables and Figures from Integrative Genomic Analysis of Pediatric Myeloid-Related Acute Leukemias Identifies Novel Subtypes and Prognostic Indicators

Maarten Fornerod,Jing Ma,Sanne Noort,Yu Liu,Michael P. Walsh,Lei Shi,Stephanie Nance,Yanling Liu,Yuanyuan Wang,Guangchun Song,Tamara Lamprecht,John Easton,Heather L. Mulder,Donald Yergeau,Jacquelyn Myers,Jennifer L. Kamens,Esther A. Obeng,Martina Pigazzi,Marie Jarosova,Charikleia Kelaidi,Sophia Polychronopoulou,Jatinder K. Lamba,Sharyn D. Baker,Jeffrey E. Rubnitz,Dirk Reinhardt,Marry M. van den Heuvel-Eibrink,Franco Locatelli,Henrik Hasle,Jeffery M. Klco,James R. Downing,Jinghui Zhang,Stanley Pounds,C. Michel Zwaan,Tanja A. Gruber

DOI: https://doi.org/10.1158/2643-3230.22543719.v1

2023-01-01

Abstract:Supplementary Tables and Figures
Tables S15-S17 from Integrative Genomic Analyses Identify LncRNA Regulatory Networks Across Pediatric Leukemias and Solid Tumors

Apexa Modi,Gonzalo Lopez,Karina L. Conkrite,Chun Su,Tsz Ching Leung,Sathvik Ramanan,Elisabetta Manduchi,Matthew E. Johnson,Daphne Cheung,Samantha Gadd,Jinghui Zhang,Malcolm A. Smith,Jaime M. Guidry Auvil,Soheil Meshinchi,Elizabeth J. Perlman,Stephen P. Hunger,John M. Maris,Andrew D. Wells,Struan F.A. Grant,Sharon J. Diskin

DOI: https://doi.org/10.1158/0008-5472.24304543

2023-01-01

Abstract:Table S15: Data integration using multi-dimensional analysis to prioritize functional lncRNAs in each cancer, Table S16: Prioritized lncRNAs and predicted lncRNA target genes and pathways in NBL, Table S17: GSEA Analysis: MSigDB Hallmarks enriched across genes impacted by siTBX2-AS1 or siTBX2 treatment in NLF
Supplementary Data-1 from Clinical Significance of Novel Subtypes of Acute Lymphoblastic Leukemia in the Context of Minimal Residual Disease–Directed Therapy

Sima Jeha,John K. Choi,Kathryn G. Roberts,Deqing Pei,Elaine Coustan‐Smith,Hiroto Inaba,Jeffrey E. Rubnitz,Raul C. Ribeiro,Tanja A. Grüber,Susana C. Raimondi,Seth E. Karol,Chunxu Qu,Samuel W. Brady,Zhaohui Gu,Jun J. Yang,Cheng,James R. Downing,Williams E. Evans,Mary V. Relling,Dario Campana,Charles G. Mullighan,Ching‐Hon Pui

DOI: https://doi.org/10.1158/2643-3230.22543365

2023-01-01

Abstract:Supplementary Data Legend, Supplementary Table (S7) and Supplementary Figures (S1-S6)
Tables S13-S14 from Integrative Genomic Analyses Identify LncRNA Regulatory Networks Across Pediatric Leukemias and Solid Tumors

Apexa Modi,Gonzalo Lopez,Karina L. Conkrite,Chun Su,Tsz Ching Leung,Sathvik Ramanan,Elisabetta Manduchi,Matthew E. Johnson,Daphne Cheung,Samantha Gadd,Jinghui Zhang,Malcolm A. Smith,Jaime M. Guidry Auvil,Soheil Meshinchi,Elizabeth J. Perlman,Stephen P. Hunger,John M. Maris,Andrew D. Wells,Struan F.A. Grant,Sharon J. Diskin

DOI: https://doi.org/10.1158/0008-5472.24304546

2023-01-01

Abstract:Table S13: lncRNAs associated with CRC of NBL, Table S14: Differentially expressed lncRNAs between major subtypes in NBL
Supplementary Excel Tables from Integrative Genomic Analysis of Pediatric Myeloid-Related Acute Leukemias Identifies Novel Subtypes and Prognostic Indicators

Maarten Fornerod,Jing Ma,Sanne Noort,Yu Liu,Michael P. Walsh,Lei Shi,Stephanie Nance,Yanling Liu,Yuanyuan Wang,Guangchun Song,Tamara Lamprecht,John Easton,Heather L. Mulder,Donald Yergeau,Jason Myers,Jennifer L. Kamens,Esther A. Obeng,Martina Pigazzi,Marie Jarošová,Charikleia Kelaïdi,Sophia Polychronopoulou,Jatinder K. Lamba,Sharyn D. Baker,Jeffrey E. Rubnitz,Dirk Reinhardt,Marry M. van den Heuvel‐Eibrink,Franco Locatelli,Henrik Hasle,Jeffery M. Klco,James R. Downing,Jinghui Zhang,Stanley Pounds,C. Michel Zwaan,Tanja A. Grüber

DOI: https://doi.org/10.1158/2643-3230.22543722.v1

2023-01-01

Abstract:Supplementary Excel Tables
Supplementary Tables 1-7 from Cumulative Effect of Multiple Loci on Genetic Susceptibility to Familial Lung Cancer

Pengyuan Liu,Haris G. Vikis,Yan Lu,Yian Wang,Ann G. Schwartz,Susan M. Pinney,Ping Yang,Mariza de Andrade,Adi Gazdar,Colette Gaba,Diptasri Mandal,Juwon Lee,Elena Kupert,Daniela Seminara,John Minna,Joan E. Bailey-Wilson,Christopher I. Amos,Marshall W. Anderson,Ming You

DOI: https://doi.org/10.1158/1055-9965.22435836.v1

2023-01-01

Abstract:Supplementary Tables 1-7 from Cumulative Effect of Multiple Loci on Genetic Susceptibility to Familial Lung Cancer
Supplementary Table 15 from Integrative Epigenomic Analysis Identifies Biomarkers and Therapeutic Targets in Adult B-Acute Lymphoblastic Leukemia

Huimin Geng,Sarah Brennan,Thomas A. Milne,Wei-Yi Chen,Yushan Li,Christian Hurtz,Soo-Mi Kweon,Lynette Zickl,Seyedmehdi Shojaee,Donna Neuberg,Chuanxin Huang,Debabrata Biswas,Yuan Xin,Janis Racevskis,Rhett P. Ketterling,Selina M. Luger,Hillard Lazarus,Martin S. Tallman,Jacob M. Rowe,Mark R. Litzow,Monica L. Guzman,C. David Allis,Robert G. Roeder,Markus Müschen,Elisabeth Paietta,Olivier Elemento,Ari M. Melnick

DOI: https://doi.org/10.1158/2159-8290.22528910

2023-01-01

Abstract:XLS file - 204K, Genomic regions enriched in MLLN, AF4C, H3K79me2 and the common of the three ChIP-seq in RS4;11 cells
Supplementary Tables from Mutational Landscape and Patterns of Clonal Evolution in Relapsed Pediatric Acute Lymphoblastic Leukemia

Esmé Waanders,Zhaohui Gu,Stephanie M. Dobson,Željko Antić,Jeremy Chase Crawford,Xiaotu Ma,Michael N. Edmonson,Debbie Payne-Turner,Maartje van de Vorst,Marjolijn C.J. Jongmans,Irina McGuire,Xin Zhou,Jian Wang,Lei Shi,Stanley Pounds,Deqing Pei,Cheng,Guangchun Song,Yiping Fan,Ying Shao,Michael Rusch,Kelly McCastlain,Jiangyan Yu,Ruben van Boxtel,Francis Blokzijl,Ilaria Iacobucci,Kathryn G. Roberts,Ji Wen,Gang Wu,Jing Ma,John Easton,Geoffrey Neale,Scott R. Olsen,Kim E. Nichols,Ching-Hon Pui,Jinghui Zhang,William E. Evans,Mary V. Relling,Jun J. Yang,Paul G. Thomas,John E. Dick,Roland P. Kuiper,Charles G. Mullighan

DOI: https://doi.org/10.1158/2643-3230.27226774

2024-01-01

Abstract:Supplementary results, figures, and table notes
Spectrum and Clinical Features of Gene Mutations in Chinese Pediatric Acute Lymphoblastic Leukemia

Diying Shen,Lixia Liu,Xiaojun Xu,Hua Song,Jingying Zhang,Weiqun Xu,Fenying Zhao,Juan Liang,Chan Liao,Yan Wang,Tian Xia,Chengcheng Wang,Feng Lou,Shanbo Cao,Jiayue Qin,Yongmin Tang

DOI: https://doi.org/10.1186/s12887-023-03856-y

2023-01-01

BMC Pediatrics

Abstract:Purpose The 5-year survival rate of children with acute lymphoblastic leukemia (ALL) is 85–90%, with a 10–15% rate of treatment failure. Next-generation sequencing (NGS) identified recurrent mutated genes in ALL that might alter the diagnosis, classification, prognostic stratification, treatment, and response to ALL. Few studies on gene mutations in Chinese pediatric ALL have been identified. Thus, an in-depth understanding of the biological characteristics of these patients is essential. The present study aimed to characterize the spectrum and clinical features of recurrent driver gene mutations in a single-center cohort of Chinese pediatric ALL. Methods We enrolled 219 patients with pediatric ALL in our single center. Targeted sequencing based on NGS was used to detect gene mutations in patients. The correlation was analyzed between gene mutation and clinical features, including patient characteristics, cytogenetics, genetic subtypes, risk stratification and treatment outcomes using χ 2 -square test or Fisher’s exact test for categorical variables. Results A total of 381 gene mutations were identified in 66 different genes in 152/219 patients. PIK3R1 mutation was more common in infants ( P = 0.021). KRAS and FLT3 mutations were both more enriched in patients with hyperdiploidy (both P < 0.001). NRAS , PTPN11 , FLT3 , and KMT2D mutations were more common in patients who did not carry the fusion genes (all P < 0.050). PTEN mutation was significantly associated with high-risk ALL patients ( P = 0.011), while NOTCH1 mutation was common in middle-risk ALL patients ( P = 0.039). Patients with ETV6 or PHF6 mutations were less sensitive to steroid treatment ( P = 0.033, P = 0.048, respectively). Conclusion This study depicted the specific genomic landscape of Chinese pediatric ALL and revealed the relevance between mutational spectrum and clinical features of Chinese pediatric ALL, which highlights the need for molecular classification, risk stratification, and prognosis evaluation.
Figure S7 from Integrative Genomic Analyses Identify LncRNA Regulatory Networks Across Pediatric Leukemias and Solid Tumors

Apexa Modi,Gonzalo Lopez,Karina L. Conkrite,Chun Su,Tsz Ching Leung,Sathvik Ramanan,Elisabetta Manduchi,Matthew E. Johnson,Daphne Cheung,Samantha Gadd,Jinghui Zhang,Malcolm A. Smith,Jaime M. Guidry Auvil,Soheil Meshinchi,Elizabeth J. Perlman,Stephen P. Hunger,John M. Maris,Andrew D. Wells,Struan F.A. Grant,Sharon J. Diskin

DOI: https://doi.org/10.1158/0008-5472.24304564

2023-01-01

Abstract:Figure S7: Validation of TBX2-AS1 expression in NBL cell lines and impact on NBL cell growth
Tables S7-S9 from Integrative Genomic Analyses Identify LncRNA Regulatory Networks Across Pediatric Leukemias and Solid Tumors

Apexa Modi,Gonzalo Lopez,Karina L. Conkrite,Chun Su,Tsz Ching Leung,Sathvik Ramanan,Elisabetta Manduchi,Matthew E. Johnson,Daphne Cheung,Samantha Gadd,Jinghui Zhang,Malcolm A. Smith,Jaime M. Guidry Auvil,Soheil Meshinchi,Elizabeth J. Perlman,Stephen P. Hunger,John M. Maris,Andrew D. Wells,Struan F.A. Grant,Sharon J. Diskin

DOI: https://doi.org/10.1158/0008-5472.24304537

2023-01-01

Abstract:Table S7: Number of TARGET samples with WGS and SCNA events per cancer identified by GISTIC, Table S8: Differential expression of genes in samples with and without SCNA, Table S9: Number of samples with SVs in lncRNAs
Supplementary Table 13 from Integrative Epigenomic Analysis Identifies Biomarkers and Therapeutic Targets in Adult B-Acute Lymphoblastic Leukemia

Huimin Geng,Sarah Brennan,Thomas A. Milne,Wei-Yi Chen,Yushan Li,Christian Hurtz,Soo-Mi Kweon,Lynette Zickl,Seyedmehdi Shojaee,Donna Neuberg,Chuanxin Huang,Debabrata Biswas,Yuan Xin,Janis Racevskis,Rhett P. Ketterling,Selina M. Luger,Hillard Lazarus,Martin S. Tallman,Jacob M. Rowe,Mark R. Litzow,Monica L. Guzman,C. David Allis,Robert G. Roeder,Markus Müschen,Elisabeth Paietta,Olivier Elemento,Ari M. Melnick

DOI: https://doi.org/10.1158/2159-8290.22528913

2023-01-01

Abstract:XLS file - 176K, DNA methylation and gene expression signature of MLLr ALL
Supplementary Table 6 from Integrative Epigenomic Analysis Identifies Biomarkers and Therapeutic Targets in Adult B-Acute Lymphoblastic Leukemia

Huimin Geng,Sarah Brennan,Thomas A. Milne,Weiyi Chen,Yushan Li,Christian Hurtz,Soo-Mi Kweon,Lynette Zickl,Seyedmehdi Shojaee,Donna Neuberg,Chuanxin Huang,Debabrata Biswas,Xin Yuan,Janis Racevskis,Rhett P. Ketterling,Selina M. Luger,Hillard M. Lazarus,Martin S. Tallman,Jacob M. Rowe,Mark R. Litzow,Mónica L. Guzmán,C. David Allis,Robert G. Roeder,Markus Müschen,Elisabeth Paietta,Olivier Elemento,Ari Melnick

DOI: https://doi.org/10.1158/2159-8290.22528898

2023-01-01

Abstract:XLS file - 45K, Detailed genes in the lymphoid gene sets and gene ontology terms
Tables S4-S6 from Integrative Genomic Analyses Identify LncRNA Regulatory Networks Across Pediatric Leukemias and Solid Tumors

Apexa Modi,Gonzalo Lopez,Karina L. Conkrite,Chun Su,Tsz Ching Leung,Sathvik Ramanan,Elisabetta Manduchi,Matthew E. Johnson,Daphne Cheung,Samantha Gadd,Jinghui Zhang,Malcolm A. Smith,Jaime M. Guidry Auvil,Soheil Meshinchi,Elizabeth J. Perlman,Stephen P. Hunger,John M. Maris,Andrew D. Wells,Struan F.A. Grant,Sharon J. Diskin

DOI: https://doi.org/10.1158/0008-5472.24304540.v1

2023-01-01

Abstract:Table S4: Top 10 expressed lncRNAs across TARGET cancers and GTEx tissues, Table S5: Tissue specificity index (tau score) annotation per gene, Table S6: Validation of tissue specific lncRNAs based on tau score analysis in alternate NBL datasets
Supplementary Materials and Methods, Supplementary Figure Legends, and Supplementary Table from Targeting the MYC and PI3K Pathways Eliminates Leukemia-Initiating Cells in T-cell Acute Lymphoblastic Leukemia

Suzanne Schubbert,Anjelica Cardenas,Harrison Chen,Consuelo Garcia,Wei Guo,James Bradner,Hong Wu

DOI: https://doi.org/10.1158/0008-5472.22404374

2023-01-01

Abstract:Supplementary Materials and Methods, Supplementary Figure Legends, and Characteristics of primary human pediatric T-ALL samples (Supplementary Table S1).
Supplementary Figure and Table Legends from NF1 Inactivation in Adult Acute Myelogenous Leukemia

Brian Parkin,Peter Ouillette,Yin Wang,Yan Liu,Whitney Wright,Diane Roulston,Anjali Purkayastha,Amanda Dressel,Judith Karp,Paula Bockenstedt,Ammar Al-Zoubi,Moshe Talpaz,Lisa Kujawski,Yang Liu,Kerby Shedden,Sajid Shakhan,Cheng Li,Harry Erba,Sami N. Malek

DOI: https://doi.org/10.1158/1078-0432.22442919

2023-01-01

Abstract:Supplementary Figure and Table Legends from NF1 Inactivation in Adult Acute Myelogenous Leukemia
Supplementary Figure Legends 1-2, Tables 1-2 from Comparison of Primary Neuroblastoma Tumors and Derivative Early-Passage Cell Lines Using Genome-Wide Single Nucleotide Polymorphism Array Analysis

Samuel L. Volchenboum,Cheng Li,Shuli Li,Edward F. Attiyeh,C. Patrick Reynolds,John M. Maris,A. Thomas Look,Rani E. George

DOI: https://doi.org/10.1158/0008-5472.22378376

2023-01-01

Abstract:Supplementary Figure Legends 1-2, Tables 1-2 from Comparison of Primary Neuroblastoma Tumors and Derivative Early-Passage Cell Lines Using Genome-Wide Single Nucleotide Polymorphism Array Analysis
Supplementary Table S8 from Biologic and Clinical Analysis of Childhood Gamma Delta T-ALL Identifies LMO2/STAG2 Rearrangements As Extremely High Risk

Shunsuke Kimura,Chun Shik Park,Lindsey E. Montefiori,Ilaria Iacobucci,Petri Pölönen,Qingsong Gao,Elizabeth D. Arnold,Andishe Attarbaschi,Anthony Brown,Barbara Buldini,Kenneth J. Caldwell,Yunchao Chang,Chelsey Chen,Cheng,Zhongshan Cheng,John Choi,Valentino Conter,Kristine R. Crews,Hester A. de Groot-Kruseman,Takao Deguchi,Mariko Eguchi,Hannah E. Muhle,Sarah Elitzur,Gabriele Escherich,Burgess B. Freeman,Zhaohui Gu,Katie Han,Keizo Horibe,Toshihiko Imamura,Sima Jeha,Motohiro Kato,Kean H. Chiew,Tanya Khan,Michal Kicinski,Stefan Köhrer,Steven M. Kornblau,Rishi S. Kotecha,Chi-Kong Li,Yen-Chun Liu,Franco Locatelli,Selina M. Luger,Elisabeth M. Paietta,Atsushi Manabe,Hanne V. Marquart,Riccardo Masetti,Mellissa Maybury,Pauline Mazilier,Jules P.P. Meijerink,Sharnise Mitchell,Takako Miyamura,Andrew S. Moore,Koichi Oshima,Katarzyna Pawinska-Wasikowska,Rob Pieters,Mollie S. Prater,Shondra M. Pruett-Miller,Ching-Hon Pui,Chunxu Qu,Michaela Reiterova,Noemi Reyes,Kathryn G. Roberts,Jacob M. Rowe,Atsushi Sato,Kjeld Schmiegelow,Martin Schrappe,Shuhong Shen,Szymon Skoczeń,Orietta Spinelli,Jan Stary,Michael Svaton,Masatoshi Takagi,Junko Takita,Yanjing Tang,David T. Teachey,Paul G. Thomas,Daisuke Tomizawa,Jan Trka,Elena Varotto,Tiffaney L. Vincent,Jun J. Yang,Allen E.J. Yeoh,Yinmei Zhou,Martin Zimmermann,Hiroto Inaba,Charles G. Mullighan

DOI: https://doi.org/10.1158/2159-8290.27168674

2024-01-01

Abstract:Lists of feature genes for expression analysis.
Supplementary Table 4 from Integrative Epigenomic Analysis Identifies Biomarkers and Therapeutic Targets in Adult B-Acute Lymphoblastic Leukemia

Huimin Geng,Sarah Brennan,Thomas A. Milne,Wei-Yi Chen,Yushan Li,Christian Hurtz,Soo-Mi Kweon,Lynette Zickl,Seyedmehdi Shojaee,Donna Neuberg,Chuanxin Huang,Debabrata Biswas,Yuan Xin,Janis Racevskis,Rhett P. Ketterling,Selina M. Luger,Hillard Lazarus,Martin S. Tallman,Jacob M. Rowe,Mark R. Litzow,Monica L. Guzman,C. David Allis,Robert G. Roeder,Markus Müschen,Elisabeth Paietta,Olivier Elemento,Ari M. Melnick

DOI: https://doi.org/10.1158/2159-8290.22528901

2023-01-01

Abstract:XLS file - 330K, Genes included in BCR-ABL1, E2A-PBX1 or MLLr DNA methylation signatures vs. normal pre-B cells
Supplementary Figure and Table Legends 1-2 from Progressive Chromatin Repression and Promoter Methylation of CTNNA1 Associated with Advanced Myeloid Malignancies

Ying Ye,Michael A. McDevitt,Mingzhou Guo,Wei Zhang,Oliver Galm,Steven D. Gore,Judith E. Karp,Jaroslaw P. Maciejewski,Jeanne Kowalski,Hua-Ling Tsai,Lukasz P. Gondek,Hsing-Chen Tsai,Xiaofei Wang,Craig Hooker,B. Douglas Smith,Hetty E. Carraway,James G. Herman

DOI: https://doi.org/10.1158/0008-5472.22381059.v1

2023-01-01

Abstract:Supplementary Figure and Table Legends 1-2 from Progressive Chromatin Repression and Promoter Methylation of CTNNA1 Associated with Advanced Myeloid Malignancies

Tables S1-S8 and Figure Legends from Novel Gene and Network Associations Found for Acute Lymphoblastic Leukemia Using Case–Control and Family-Based Studies in Multiethnic Populations

Supplementary Tables and Figures from Integrative Genomic Analysis of Pediatric Myeloid-Related Acute Leukemias Identifies Novel Subtypes and Prognostic Indicators

Tables S15-S17 from Integrative Genomic Analyses Identify LncRNA Regulatory Networks Across Pediatric Leukemias and Solid Tumors

Supplementary Data-1 from Clinical Significance of Novel Subtypes of Acute Lymphoblastic Leukemia in the Context of Minimal Residual Disease–Directed Therapy

Tables S13-S14 from Integrative Genomic Analyses Identify LncRNA Regulatory Networks Across Pediatric Leukemias and Solid Tumors

Supplementary Excel Tables from Integrative Genomic Analysis of Pediatric Myeloid-Related Acute Leukemias Identifies Novel Subtypes and Prognostic Indicators

Supplementary Tables 1-7 from Cumulative Effect of Multiple Loci on Genetic Susceptibility to Familial Lung Cancer

Supplementary Table 15 from Integrative Epigenomic Analysis Identifies Biomarkers and Therapeutic Targets in Adult B-Acute Lymphoblastic Leukemia

Supplementary Tables from Mutational Landscape and Patterns of Clonal Evolution in Relapsed Pediatric Acute Lymphoblastic Leukemia

Spectrum and Clinical Features of Gene Mutations in Chinese Pediatric Acute Lymphoblastic Leukemia

Figure S7 from Integrative Genomic Analyses Identify LncRNA Regulatory Networks Across Pediatric Leukemias and Solid Tumors

Tables S7-S9 from Integrative Genomic Analyses Identify LncRNA Regulatory Networks Across Pediatric Leukemias and Solid Tumors

Supplementary Table 13 from Integrative Epigenomic Analysis Identifies Biomarkers and Therapeutic Targets in Adult B-Acute Lymphoblastic Leukemia

Supplementary Table 6 from Integrative Epigenomic Analysis Identifies Biomarkers and Therapeutic Targets in Adult B-Acute Lymphoblastic Leukemia

Tables S4-S6 from Integrative Genomic Analyses Identify LncRNA Regulatory Networks Across Pediatric Leukemias and Solid Tumors

Supplementary Materials and Methods, Supplementary Figure Legends, and Supplementary Table from Targeting the MYC and PI3K Pathways Eliminates Leukemia-Initiating Cells in T-cell Acute Lymphoblastic Leukemia

Supplementary Figure and Table Legends from NF1 Inactivation in Adult Acute Myelogenous Leukemia

Supplementary Figure Legends 1-2, Tables 1-2 from Comparison of Primary Neuroblastoma Tumors and Derivative Early-Passage Cell Lines Using Genome-Wide Single Nucleotide Polymorphism Array Analysis

Supplementary Table S8 from Biologic and Clinical Analysis of Childhood Gamma Delta T-ALL Identifies LMO2/STAG2 Rearrangements As Extremely High Risk

Supplementary Table 4 from Integrative Epigenomic Analysis Identifies Biomarkers and Therapeutic Targets in Adult B-Acute Lymphoblastic Leukemia

Supplementary Figure and Table Legends 1-2 from Progressive Chromatin Repression and Promoter Methylation of CTNNA1 Associated with Advanced Myeloid Malignancies